HPV Vaccination in India: Critical Appraisal
- PMID: 25006481
- PMCID: PMC3967597
- DOI: 10.1155/2014/394595
HPV Vaccination in India: Critical Appraisal
Abstract
Cervical cancer is the third most common cancer in women worldwide. The role of human papilloma virus (HPV) in the genesis of cervical carcinoma is well documented. The HPV 16 and 18 are found to be most commonly associated with invasive cervical carcinoma. The advent of cervical carcinoma vaccine has advanced the hopes that eradication of cervical carcinoma might be possible in future. The scenario of prevention of cervical carcinoma is completely different in developed and developing countries. The implementation of the vaccination as a routine in India is still controversial. Here we have tried to critically analyse these issues in Indian context. However it is clear that cervical cancer vaccine is not an immediate panacea and cannot replace the cervical cancer screening which is mandatory in Indian context.
References
-
- Saxena U, Sauvaget C, Sankaranarayanan R. Evidence based Screening, early diagnosis and treatment strategy of cervical cancer for national policy in low resource countries: example of India. Asian Pacific Journal of Cancer Prevention. 2012;13:1699–1703. - PubMed
-
- Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN, 2002 Cancer Incidence, Mortality and Prevalence Worldwide. Lyon, France: IARC Press; 2004. (Version 1. 0. IARC Cancer Base No. 5).
-
- Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology. 1999;189:12–19. - PubMed
-
- Evander M, Edlund K, Gustafsson A, et al. Human papillomavirus infection is transient in young women: a population-based cohort study. Journal of Infectious Diseases. 1995;171(4):1026–1030. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
